Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

AXIOM IMPLANT PX ?3.4 x 12.0: medical device reports filed with FDA

1,997 reports name it, 2021–2026. Manufacturer given most often on reports: Anthogyr. Product code DZE.

1,997
device reports naming the brand
0% of all MAUDE reports · about 369 a year
484
reports, 12 months to August 2026
446 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,997 reports that name the brand "AXIOM IMPLANT PX ?3.4 x 12.0" (endosseous dental implant), received between February 2021 and August 2026; the manufacturer given most often on reports is Anthogyr. Spellings of one product vary from report to report.

484 reports arrived in the 12 months to August 2026, close to the 446 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (85.3%), loss of osseointegration (12.6%) and fracture (0.6%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

058116Sep 2021: 4Oct 2021: 15Nov 2021: 34Dec 2021: 162022Jan 2022: 59Feb 2022: 31Mar 2022: 10Apr 2022: 18May 2022: 18Jun 2022: 29Jul 2022: 40Aug 2022: 20Sep 2022: 33Oct 2022: 16Nov 2022: 26Dec 2022: 352023Jan 2023: 13Feb 2023: 12Mar 2023: 14Apr 2023: 17May 2023: 17Jun 2023: 45Jul 2023: 39Aug 2023: 29Sep 2023: 38Oct 2023: 28Nov 2023: 28Dec 2023: 402024Jan 2024: 35Feb 2024: 19Mar 2024: 22Apr 2024: 31May 2024: 31Jun 2024: 22Jul 2024: 22Aug 2024: 30Sep 2024: 29Oct 2024: 25Nov 2024: 30Dec 2024: 412025Jan 2025: 21Feb 2025: 26Mar 2025: 57Apr 2025: 13May 2025: 0Jun 2025: 116Jul 2025: 35Aug 2025: 53Sep 2025: 45Oct 2025: 48Nov 2025: 35Dec 2025: 542026Jan 2026: 31Feb 2026: 24Mar 2026: 43Apr 2026: 37May 2026: 21Jun 2026: 51Jul 2026: 45Aug 2026: 50

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02525032021: 20020212022: 33520222023: 32020232024: 33720242025: 50320252026: 3022026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,997
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,997
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,70485.3%62.8%
Loss of osseointegration25112.6%22.4%
Fracturea broken bone120.6%1.6%
Difficult to insertthe device was hard to insert40.2%0.4%
Separation failure20.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis33116.6%
Painpain, site not specified1879.4%
Inflammationinflammation924.6%
Swelling/ edema894.5%
Hemorrhage/blood loss/bleeding452.3%
Numbnessnumbness251.3%
Fistula201%
Hypersensitivity/allergic reaction130.7%
Abscessa collection of pus110.6%
Hyperresponsive to stimuli80.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAXIOM IMPLANT PX ?3.4 x 12.0Product code DZEAll MAUDE reports
Reports1,9973,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about AXIOM IMPLANT PX ?3.4 x 12.0 reports

How many FDA reports name AXIOM IMPLANT PX ?3.4 x 12.0?

1,997 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 484 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (85.3%), loss of osseointegration (12.6%), fracture (0.6%), difficult to insert (0.2%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that AXIOM IMPLANT PX ?3.4 x 12.0 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.